Search

Filters

Clear Filters
5:20 PM - 5:25 PM PT

1096 - Multimodal Imaging of the Functional and Physiological Bone Marrow Microenvironment in AML: Toward Personalized Clinical Applications
Speaker: Hui, Susanta, PhD - City of Hope National Medical Center, Duarte, CA
5:25 PM - 5:30 PM PT

1097 - Response Rate and Local Control of Response-Adapted Very Low Dose Radiotherapy (RA-VLDRT) with 4 Gy for Indolent Non-Hodgkin Lymphoma
Speaker: Mankuzhy, Nikhil, MD - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ
5:30 PM - 5:35 PM PT

1098 - Optimizing Palliative Radiation Therapy for Primary Cutaneous B-Cell Lymphoma: Is Ultra-Low Dose (4 Gy) Enough?
Speaker: Gard, Gabrielle, BS - University of Texas Southwestern Medical Center, Dallas, TX
5:35 PM - 5:40 PM PT

1099 - Bridging Radiotherapy for Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
Speaker: Daniels, Kristin, BS - UC San Diego School of Medicine, La Jolla, CA
3:00 PM - 3:10 PM PT

110 - IMPARC: A Prospective Trial of Stereotactic Proton Reirradiation for Locoregionally Recurrent Rectal Cancer
Speaker: Dalwadi, Poonam, MD, BS - Washington University/B-JH/SLCH Consortium, St. Louis, MO
5:40 PM - 5:45 PM PT

1100 - A Multi-Model Machine Learning Framework Identifies Resistance-Associated Biomarkers in Axicabtagene Ciloleucel CAR T-Cell Therapy for Large B-Cell Lymphoma
Speaker: Xing, Lei, PhD, FASTRO - Stanford University, Stanford University, CA
5:45 PM - 5:50 PM PT

1101 - Consensus Organ at Risk (OAR) Constraints for Radiotherapy (RT) for Hematologic Malignancies for NCTN Trials
Speaker: Sim, Austin, MD, JD - The Ohio State University Comprehensive Cancer Center, Columbus, OH
5:00 PM - 6:00 PM PT

1102 - CDCA3 Promotes Radiotherapy Resistance in Lung Adenocarcinoma by Facilitating Non-Homologous End Joining
Speaker: Lai, Tangmin, MS - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, Chongqing
5:20 PM - 5:26 PM PT

1103 - SETD2 Loss Predicts Response to Chemoradiotherapy in Rectal Cancer: Clinical Outcomes and Preclinical Validation in Orthotopic Models
Speaker: Megahed, Romy, MD - UAMS Radiation Oncology, Little Rock, AR
5:26 PM - 5:32 PM PT

1104 - Radiation-Induced HACE1 Suppression Drives Metastatic Progression in Lung Cancer through Actin Cytoskeletal Remodeling
Speaker: Huang, Hao, PhD - Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xian, Shanxi
5:32 PM - 5:38 PM PT

1105 - The Sparing Effect of FLASH Radiotherapy on Intestinal Tissue in Mice Using Conventional Fractionation
Speaker: Wang, Weiping, MD, PhD - Peking Union Medical College Hospital, Beijing, Beijing
5:38 PM - 5:44 PM PT

1106 - First In Vitro and In Vivo Oxygen Ion FLASH Experiments with a Pancreatic Cancer Model
Speaker: Karle, Celine, MS - German Cancer Research Center (DKFZ), Heidelberg, Baden-Wurt